Shares of ResMed (RMD) fall 4.4% premarket after the firm misses Q3 EPS estimates by $0.02 on...

|About: ResMed Inc. (RMD)|By:, SA News Editor

Shares of ResMed (RMD) fall 4.4% premarket after the firm misses Q3 EPS estimates by $0.02 on revenue of $315M (+12% Y/Y). The company reports that its sales were hurt by a weak U.S. dollar in relation to the Euro and Aussie dollar.